Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

ProImmune Collaborates with The University of Texas Medical Branch to Advance Infectious Disease Research

The teams will validate small engineered binding reagents for 60 pathogens and disease vectors to support high-containment viral research and vaccine development.

Summary by WBOC 16
Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and

2 Articles

WBOC 16WBOC 16
Reposted by
News MedicalNews Medical
Center

ProImmune Collaborates with The University of Texas Medical Branch to Advance Infectious Disease Research

Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WBOC 16 broke the news in on Tuesday, April 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical icon

Medical

Vaccines icon

Vaccines

Galveston icon

Galveston

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal